Abstract:Intracellular calcium (Ca2+) concentration ([Ca2+]i) is a key determinant of cell fate and is implicated in carcinogenesis. Membrane ion channels are structures through which ions enter or exit the cell, depending on the driving forces. The opening of transient receptor potential vanilloid 1 (TRPV1) ligand-gated ion channels facilitates transmembrane Ca2+ and Na+ entry, which modifies the delicate balance between apoptotic and proliferative signaling pathways. Proliferation is upregulated through two mechanisms: (1) ATP binding to the G-protein-coupled receptor P2Y2, commencing a kinase signaling cascade that activates the serine-threonine kinase Akt, and (2) the transactivation of the epidermal growth factor receptor (EGFR), leading to a series of protein signals that activate the extracellular signal-regulated kinases (ERK) 1/2. The TRPV1-apoptosis pathway involves Ca2+ influx and efflux between the cytosol, mitochondria, and endoplasmic reticulum (ER), the release of apoptosis-inducing factor (AIF) and cytochrome c from the mitochondria, caspase activation, and DNA fragmentation and condensation. While proliferative mechanisms are typically upregulated in cancerous tissues, shifting the balance to favor apoptosis could support anti-cancer therapies. TRPV1, through [Ca2+]i signaling, influences cancer cell fate; therefore, the modulation of the TRPV1-enforced proliferation–apoptosis balance is a promising avenue in developing anti-cancer therapies and overcoming cancer drug resistance. As such, this review characterizes and evaluates the role of TRPV1 in cell death and survival, in the interest of identifying mechanistic targets for drug discovery.

The L‐type calcium channel CaV1.3: A potential target for cancer therapy

Targeting calcium signaling in cancer therapy

Proton-sensing ion channels, GPCRs and calcium signaling regulated by them: implications for cancer

Development and therapeutic implications of small molecular inhibitors that target calcium ion-related channels in tumor treatment

The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies

The Regulatory Roles of Calcium Channels in Tumors

Calcium Entry through TRPV1: A Potential Target for the Regulation of Proliferation and Apoptosis in Cancerous and Healthy Cells

New frontiers in the design and discovery of therapeutics that target calcium ion signaling: a novel approach in the fight against cancer

Intermediate conductance calcium-activated potassium channel (KCa3.1) in cancer: Emerging roles and therapeutic potentials

Low-voltage-activated T-type Ca 2+ Channel Inhibitors As New Tools in the Treatment of Glioblastoma: the Role of Endostatin

T-Type Calcium Channels: A Mixed Blessing

Recent Developments on the Roles of Calcium Signals and Potential Therapy Targets in Cervical Cancer

Connecting Calcium-Based Nanomaterials and Cancer: from Diagnosis to Therapy

Calcium-based Nanotechnology for Cancer Therapy

Volume-regulated anion channel as a novel cancer therapeutic target

Calcium and CaSR/IP3R in Prostate Cancer Development

Ligand-Gated Ion Channels as Targets for Treatment and Management of Cancers

Ca2+ Homeostasis: a Potential Target for Cancer Therapies

TMEM16A ion channel: A novel target for cancer treatment

ORAI Ca2+ Channels in Cancers and Therapeutic Interventions

Voltage-gated potassium channel 1.3: A promising molecular target in multiple disease therapy